Business Description
Onco-Innovations Ltd
NAICS : 541710
SIC : 3741
ISIN : CA68237C1059
Description
Onco-Innovations Ltd is a preclinical-stage biotechnology company developing drug candidates that can have the potential to increase the effectiveness of current cancer treatments or function as monotherapy in biomarker-selected cancers. Its main product candidate, ONC010, is a novel inhibitor of the DNA repair enzyme PNKP in a nanoparticle formulation. ONC010 has undergone in vitro and in vivo testing in human cancer cells and mice, respectively, and has demonstrated an ability to increase the effectiveness of current cancer treatments, as well as induce synthetic lethality in phosphatase and tensin homologue (PTEN)-deficient cells.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.31 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -23 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.57 | |||||
9-Day RSI | 43.46 | |||||
14-Day RSI | 42.31 | |||||
3-1 Month Momentum % | -36.36 | |||||
12-1 Month Momentum % | -63.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 0.91 | |||||
Days Sales Outstanding | 104.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.9 | |||||
Shareholder Yield % | -9.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -9704.51 | |||||
Net Margin % | -9709.01 | |||||
EBITDA Margin % | -9704.51 | |||||
FCF Margin % | -4745.95 | |||||
OCF Margin % | -4745.95 | |||||
ROE % | -992.17 | |||||
ROA % | -659.71 | |||||
ROIC % | -2049.86 | |||||
ROC (Joel Greenblatt) % | -2268.98 | |||||
ROCE % | -991.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 560 | |||||
PB Ratio | 80 | |||||
Price-to-Tangible-Book | 56 | |||||
EV-to-EBIT | -3.48 | |||||
EV-to-EBITDA | -3.48 | |||||
EV-to-Revenue | 337.64 | |||||
EV-to-FCF | -6.85 | |||||
| Price-to-Net-Current-Asset-Value | 56 | |||||
Earnings Yield (Greenblatt) % | -28.76 | |||||
FCF Yield % | -13.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onco-Innovations Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.111 | ||
| EPS (TTM) (C$) | -0.19 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 113.21 | ||
| 14-Day RSI | 42.31 | ||
| 14-Day ATR (C$) | 0.063393 | ||
| 20-Day SMA (C$) | 0.5995 | ||
| 12-1 Month Momentum % | -63.16 | ||
| 52-Week Range (C$) | 0.35 - 1.98 | ||
| Shares Outstanding (Mil) | 68.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onco-Innovations Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onco-Innovations Ltd Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onco-Innovations Ltd Frequently Asked Questions
What is Onco-Innovations Ltd(NEOE:ONCO)'s stock price today?
The current price of NEOE:ONCO is C$0.56. The 52 week high of NEOE:ONCO is C$1.98 and 52 week low is C$0.35.
When is next earnings date of Onco-Innovations Ltd(NEOE:ONCO)?
The next earnings date of Onco-Innovations Ltd(NEOE:ONCO) is .
Does Onco-Innovations Ltd(NEOE:ONCO) pay dividends? If so, how much?
Onco-Innovations Ltd(NEOE:ONCO) does not pay dividend.
Press Release
Articles on Onco-Innovations Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers